Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): A protocol for a randomised controlled trial

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Leistner, Stefanie ^a   Michelson, Georg ^b   Laumeier, Inga ^a   Ahmadi, Michael ^a   Smyth, Maureen ^a   Nieweler, Gabriele ^a   Doehner, Wolfram ^a   Sobesky, Jan ^a   Fiebach, Jochen B ^a   Marx, Peter ^a   Busse, Otto ^c   Köhler, Friedrich ^a   Poppert, Holger ^d   Wimmer, Martin L J ^e   Knoll, Thomas ^e   Von Weitzel Mudersbach, Paul ^f   Audebert, Heinrich J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Deutsche Schlaganfall Gesellschaft   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Gemeinschaftspraxis DrmedThomas Knoll   (Germany)

^f Department of Neurology ^*  (Denmark)

Author keywords

Intervention trial; Secondary prevention; Stroke; TIA

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; SIMVASTATIN;

ADULT; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; FEEDBACK SYSTEM; FOLLOW UP; HEALTH PROGRAM; HEART DEATH; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MOTIVATION; MOTIVATIONAL INTERVIEWING; MULTICENTER STUDY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; STROKE PATIENT; SUPPORT PROGRAM; TRANSIENT ISCHEMIC ATTACK;

ADMINISTRATION, ORAL; ADULT; AMINO ACIDS; ANTICOAGULANTS; BIAS (EPIDEMIOLOGY); DISEASE-FREE SURVIVAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MIDDLE AGED; RISK FACTORS; SAMPLE SIZE; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 84872675138     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-11     Document Type: Article

References (38)

1. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041. PROGRESS Collaborative Group.
2. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008, 359:1238-1251. 10.1056/NEJMoa0805002, 2714259, 18753638.
3. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559.
4. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295:180-189. 10.1001/jama.295.2.180, 16403930.
5. Rother J, Alberts MJ, Touze E, Mas JL, Hill MD, Michel P, et al. Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis 2008, 25:366-374. 10.1159/000120687, 18337635.
6. Alberts MJ, Bhatt DL, Mas JL, Ohman EM, Hirsch AT, Rother J, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009, 30:2318-2326. 10.1093/eurheartj/ehp355, 2755116, 19720633.
7. Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology 2011, 77:1182-1190. 10.1212/WNL.0b013e31822f0423, 3265047, 21900638.
8. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369. 10.1001/jama.289.18.2363, 12746359.
9. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393. 10.1056/NEJMoa021778, 12556541.
10. Moreno Palanco MA, Ciria De Pablo C, Ibanez Sanz P, Sanchez Luis C, Pizarro Portillo A, Suarez Fernandez C. Cardiovascular morbimortality reduction after an acute cardiovascular event through multifactorial and intensive cardiovascular risk factors management (MIRVAS project). Med Clin (Barc) 2007, 129:241-246.
11. Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008, 168:2194-2204. 10.1001/archinte.168.20.2194, 19001195.
12. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008, 299:2857-2867. 10.1001/jama.299.24.2857, 2715866, 18577730.
13. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591. 10.1056/NEJMoa0706245, 18256393.
14. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011, 365:993-1003. 10.1056/NEJMoa1105335, 3552515, 21899409.
15. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305-1316. 10.1056/NEJMoa043033, 15800226.
16. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41. 10.1161/01.STR.24.1.35, 7678184.
17. Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007, 6:953-960. 10.1016/S1474-4422(07)70248-X, 17928270.
18. Liu L, Wang Z, Gong L, Zhang Y, Thijs L, Staessen JA, et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res 2009, 32:1032-1040. 10.1038/hr.2009.139, 19798097.
19. Leistner S, Benik S, Laumeier I, Ziegler A, Nieweler G, Nolte CH, Heuschmann PU, Audebert HJ. Secondary Prevention after Minor Stroke and TIA - Usual Care and Development of a Support Program. PLoS One 2012, 7(12):e49985. 10.1371/journal.pone.0049985, 3524242, 23284630.
20. Duchateau L, Janssen P. The Frailty Model 2007, Springer-Verlag GmbH.
21. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006, 367:1665-1673.
22. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011, 42:1489-1494. 10.1161/STROKEAHA.110.602615, 21454819.
23. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993, 342:1255-1262. EAFT (European Atrial Fibrillation Trial) Study Group.
24. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998, 339:1415-1425. 10.1056/NEJM199811123392002, 9811916.
25. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284:2901-2906. 10.1001/jama.284.22.2901, 11147987.
26. Lawrence M, Kerr S, Watson H, Paton G, Ellis G. An exploration of lifestyle beliefs and lifestyle behaviour following stroke: findings from a focus group study of patients and family members. BMC Fam Pract 2010, 11:97. 10.1186/1471-2296-11-97, 3018456, 21143874.
27. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370:1432-1442. 10.1016/S0140-6736(07)61448-2, 17928046.
28. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245. 10.1001/jama.291.10.1238, 15010446.
29. PREVENTS Trial The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attach or Stroke Trial 2012, [cited 2012 August 2012]; Available from: http://clinicaltrials.gov/ct2/show/NCT01020851?term=NCT+01020851&rank=1, PREVENTS Trial.
30. The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study 2012, [cited August 2012]; Available from: http://clinicaltrials.gov/ct2/show/NCT00253097?term=NCT+00253097&rank=1.
31. Hedegaard U. Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication (NCT01684176) 2012, [cited 2012 07.11.2012]; Available from: http://clinicaltrials.gov/ct2/show/NCT01684176?term=Tailored+Intervention+to+Improve+Patient+Adherence+to+Secondary+Stroke+Prevention+Medication&rank=1.
32. Jackson D. Reducing disabiility in older Australians through secondary stroke prevention (ACTRN12611000264987) 2011, [cited 2012 05.11.2012]; Available from: http://www.anzctr.org.au/trial_view.aspx?ID=336582.
33. Fratini M. A cluster randomized controlled trial to evaluate a disease and care-management intervention for cardiovascular prevention in primary care: The Raffaello Project. (ACTRN12611000813987). http://www.anzctr.org.au/ACTRN12611000813987.
34. Rochette A, Korner-Bitensky N, Bishop D, Teasell R, White C, Bravo G, et al. Study protocol of the YOU CALL-WE CALL TRIAL: impact of a multimodal support intervention after a "mild" stroke. BMC Neurol 2010, 10:3. 10.1186/1471-2377-10-3, 2818655, 20053273.
35. Cheng EM. Development of a Stroke Prevention Program for an Underserved Minority Community (NCT01071408) 2010, [cited 2012 07.11.2012]; Available from: http://clinicaltrials.gov/ct2/show/NCT01071408?term=Development+of+a+Stroke+Prevention+Program+for+an+Underserved+Minority+Community&rank=1.
36. McAlister FA. Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack (PREVENTION) (NCT00931788) 2009, [cited 2012 07.11.2012]; Available from: http://clinicaltrials.gov/ct2/show/NCT00931788?term=Preventing+Recurrent+Vascular+Events++in+Patients+With+Stroke+or+Transient+Ischemic+Attack&rank=1.
37. Yongjun W. STroke inpatient secOndary Prevention: current status and continuous care improvement (ISRCTN17207064) 2007, [cited 2012 07.11.2012]; Available from: http://www.controlled-trials.com/ISRCTN17207064/secondary+prevention.
38. Wedge N. IMproving the PRevention Of Vascular Events after stroke or transient ischemic attack, the IMPROVE pilot trial (ISRCTN63816609) 2012, [cited 2012 07.11.2012]; Available from: http://www.controlled-trials.com/ISRCTN63816609/secondary+prevention.